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1. Introduction
Ozone is a natural gas consisting of three oxygen atoms that has a distinctive odor. It is
intrinsically hazardous over tolerable doses for living organisms. Ozone therapy is a medical
therapy that a mixture of oxygen and ozone which is called medical ozone is used as a medical
drug, more correctly pro-drug. Medical ozone contains less than 5% of ozone at maximum
concentration where rest of it is pure medical oxygen.
The unbelievable versatility of ozone therapy is due to the cascade of ozone-derived com‐
pounds able to act on several targets leading to a multifactorial correction of various patho‐
logical states. Ozone therapy can improve well-being and delay the negative effects of aging.
Aging process basicly related with oxidants and anti-oxidants balance, Advanced Glycoslation
End Substances (AGEs), role of genes and immune system, relevance of telomeres and
telomerase, hormones, nutrition, environmental factors and some other factors.
2. What is ozone therapy?
Ozone therapy is a general termination of a medical therapy that medical ozone gas is used as
drug by several methods. Some of these methods are systemic where many others are local
applications. Ozonated autohaemotherapy (O3-AHT) widely known by people firstly descri‐
bed by Wehrli and Steinbart and since 1954 it has been used in millions of patients in different
pathologies with apparent clinical benefit. AHT might be applied in two forms, Major AHT
simply driving 100-150 ml of venous blood into a sterile bottle made of neutral glass or other
ozone resistant material where blood and medical ozone is mixed in therapeutic doses and
then reinfused back to the donor without side effects. 3.13 % Natrium Citrate solution is used
as an anticoagulant during the procedure with short lasting effect. In some patients Heparin
might be used instead of Natrium Citrate depending on the patient’s case.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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Figure 1. Schematic drawing of the components necessary to perform major autohematherapy
Minor AHT is very similar to major AHT method with a few differences, where 5-10 ml of
blood is mixed with precise dose of medical ozone in a syringe and reinjected by intramuscular
route to the donor that no anticoagulant is used. Rectal insufflation (RI) of medical ozone gas
is another method of systemic ozone therapy that is applied on some cases if others methods
cannot be done or this method is preferred over others due to diseases.
Ozone is normally present as gas made of three atoms of oxygen with a cyclic structure. The
medical generator of ozone produces it from pure oxygen passing through a high voltage
gradient (5-13 mV) according to the reaction.
+ ®  2 3 3O 68,400cal 2O (1)
Ozone is 1.6 fold denser and 10-fold more soluble in water (49.0 mL in 100 mL water at 0_C)
than oxygen. Although ozone is not a radical molecule, it is the third most potent oxidant (E_5
12.076 V) after fluorine and persulfate. Ozone is an unstable gas that cannot be stored and
should be used at once because it has a half life of 40 min at 20_C
2.1. What is the behavior and fate of ozone after coming in contact with body fluids?
The essential concepts to bear in mind are the following;
a. As any other gas, ozone dissolves physically in pure water according to Henry’s Law in
relation to temperature, pressure and ozone concentration. Only in this situation ozone
does not react and in a tightly closed glass bottle, the ozonated water is useful as a
disinfectant that remains active for a couple of days
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b. On the other hand, at variance with oxygen, ozone reacts immediately as soon as it is
dissolved in biological water (physiological saline, plasma, lymph, urine)
+ ® +  3 2O biomolecules O O, (2)
Where atomic oxygen behaves as a very reactive atom. Contrary to the incorrect belief that
ozone penetrates through the skin and mucosae or enters into the cells, it is emphasized that,
after the mentioned reaction, ozone does not exist any longer. In order of preference, ozone
reacts with polyunsaturated fatty acids (PUFA), antioxidants such as ascorbic and uric acids,
thiol compounds with-SH groups such as cysteine, reduced glutathione (GSH) and albumin.
Depending upon the ozone dose, carbohydrates, enzymes, DNA and RNA can also be affected.
All of these compounds act as electron donor and undergo oxidation.
c. The main reaction:
- = - + + ® - = + - = +    3 2 2 2R CH CH R O H O R CH O R CH O H O (3)
shows the simultaneous formation of one mole of hydrogen peroxide (included among reactive
oxygen species, ROS) and of two moles of lipid oxidation products (LOPs) [12].
The fundamental ROS molecule is hydrogen peroxide, which is a non-radical oxidant able to
act as an ozone Messenger responsible for eliciting several biological and therapeutic effects
[13,14]. The concept that ROS are always harmful has been widely revised because, in
physiological amounts, they act as regulators of signal transduction and represent important
mediators of host defense and immune responses. Presence of traces of Fe++should be avoided
because, in the presence of hydrogen peroxide, via the Fenton’s reaction, they will catalyze the
formation of the most reactive OH, (hydroxyl radical).
It is determined [15] that the formation of nitrogen monoxide (NO,) in human endothelial cells
exposed to ozonated serum. Attention should be paid to the fact that an excess of ROS can lead
to the formation of other toxic compounds such as peroxynitrite (O=NOO-) and hypochlorite
anion (ClO-).
Although ROS have a lifetime of less than a second, they can damage crucial cell components
and, therefore, their generation must be precisely calibrated to achieve a biological effect
without any damage. This can be achieved by regulating the ozone dose (ozone concentration
as mg/mL of gas per mL of blood in 1:1 ratio) against the antioxidant capacity of blood that
can be measured and, if necessary, strengthened by oral administration of antioxidants before
and throughout ozone therapy.
d. LOPs production follows peroxidation of PUFA present in the plasma: they are hetero‐
geneous and can be classified as lipoperoxides (LOO,), alkoxyl radicals (LO,), lipohydro‐
peroxides (LOOH), isoprostanes and alkenals, among which are 4-hydroxy-2,3
transnonenal (HNE) and malonyldialdehyde (MDA). Radicals and aldehydes are
intrinsically toxic and must be generated in very low concentrations. They are in vitro far
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more stable (6) than ROS but fortunately, upon blood reinfusion, they undergo a marked
dilution in body fluids, excretion (via urine and bile), and metabolism by GSH-transferase
(GSH-Tr) and aldehyde dehydrogenases. Thus, only submicromolar concentrations can
reach all organs, particularly bone marrow, liver, central nervous system (CNS), endocrine
glands, etc., where they act as signaling molecules of an ongoing acute oxidative stress
[16].
If the stage of the disease is not too far advanced, these molecules can elicit the upregulation
of antioxidant enzymes such as superoxide dismutase (SOD), GSH-peroxidases (GSH-Px),
GSH-reductase (GSH-Rd) and catalase (CAT). Interestingly, Iles and Liu [17] have just
demonstrated that HNE, by inducing the expression of glutamate cysteine ligase, causes an
intracellular increase of GSH, which plays a key role in antioxidant defense. Furthermore,
LOPs induce oxidative stress proteins, one of which is heme-oxygenase I (HO-1 or HSP-32)
which, after breaking down the heme molecule, delivers very useful compounds such as CO
and bilirubin [18]. Bilirubin is a significant lipophilic antioxidant and a trace of CO cooperates
with NO in regulating vasodilation by activating cyclic GMP. Fe++is promptly chelated by
upregulated ferritin. The induction of HO-1 after an oxidative stress has been described in
hundreds of papers as one of the most important antioxidant defense and protective enzyme.
Moreover, LOPs exert a neuroimmunomodulatory effect highlighted by a feeling of well being
reported by patients during ozone therapy.
Although it remains hypothetical, it is possible that LOP, throughout the treatments, acting as
acute oxidative stressors in the bone marrow microenvironments activate the release of
metalloproteinases, of which MP-9 particularly may favor the detachment of staminal cells
[11]. These cells, once in the blood circulation, may be attracted and home at sites where a
previous injury (a trauma or an ischemic-degenerative event) has taken place. The potential
relevance of such an event would have a huge practical importance and will avoid the
unnatural, costly and scarcely effective practice of the bone marrow collection with the need
of the successive and uncertain reinfusion [19].
It is emphasized that submicromolar LOPs levels can be stimulatory and beneficial, whereas
high levels can be toxic. This conclusion, based on many experimental data [16], reinforces the
concept that optimal ozone concentrations are critical for achieving a therapeutic result: too
low concentrations are practically useless (at best elicit a placebo effect), too high may elicit a
negative effect (malaise, fatigue) so that they must be just above the threshold level to yield an
acute, absolutely transitory oxidative stress capable of triggering biological effects without
toxicity. In conclusion, it must be clear that the ozonation process either happening in blood,
or intradiscal or in an intramuscular site represents an acute oxidative stress. However,
provided that it is precisely calculated according to a judicious ozone dosage, it is not delete‐
rious but is actually capable of eliciting a multitude of useful biological responses and, possibly,
can reverse a chronic oxidative stress due to aging, chronic infections, diabetes, atherosclerosis,
degenerative processes and cancer. Indeed, the ozonotherapeutic act is interpreted as an atoxic
but real ‘‘therapeutic shock’’ able to restore homeostasis.
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2.2. Which are the biological effects elicited by ROS and LOPs?
The ozonation process is therefore characterized by the formation of ROS and LOPs acting in
two phases. This process happens either ex vivo (as a typical example in the blood collected
in a glass bottle) or in vivo (after an intramuscular injection of ozone) but while ROS are acting
immediately and disappear (early and short-acting messengers), LOPs, via the circulation,
distribute throughout the tissues and eventually only a few molecules bind to cell receptors.
Their pharmacodynamics allow minimizing their potential toxicity and allows them to become
late and long-lasting messengers.
Formation of ROS in the plasma is extremely rapid and is accompanied by a transitory and
small ozone dosedependent decrease (ranging from 5 to 25%) of the antioxidant capacity.
Importantly, this return to normal within 15–20 min owes to the efficient recycling of oxidized
compounds such as dehydroascorbate to ascorbic acid [20]. H2O2 diffuses easily from the
plasma into the cells and its sudden appearance in the cytoplasm represents the triggering
stimulus: depending upon the cell type, different biochemical pathways can be concurrently
activated in erythrocytes, leukocytes and platelets resulting in numerous biological effects. It
must be noted that between the plasma and the cytoplasm compartments there is a gradient
and the intracellular H2O2 concentration is only about 1/10 of the plasmatic one [21]. The rapid
reduction to water is operated by the high concentration of GSH, CAT and GSH-Px; nonethe‐
less, H2O2 must be above the threshold concentration for activating several biochemical
pathways.
Let us now examine how hydrogen peroxide, now universally recognized as one of the main
intracellular signalling molecules [13], acts on the different blood cells. The mass of erythro‐
cytes mops up the bulk of hydrogen peroxide: GSH is promptly oxidized to GSSG and the cell,
extremely sensitive to the reduction of the GSH/GSSG ratio, immediately corrects the unbal‐
ance by either extruding GSSG or reducing it with GSH-Rd at the expense of ascorbate or of
the reduced nicotinamide adenine dinucleotide phosphate (NADPH), which serves as a crucial
electron donor. Next, the oxidized NADP is reduced after the activation of the pentose
phosphate pathway, of which glucose-6-phosphate dehydrogenase (G-6PD) is the key enzyme.
It is determined that a small but significant increase of ATP formation [10,11], but whether this
is due to the activation of the pentose cycle or to phosphofructokinase or to both remains to
be clarified. Moreover, for a brief period the reinfused erythrocytes enhance the delivery of
oxygen into ischemic tissues because of a shift to the right of the oxygen–hemoglobin disso‐
ciation curve, due either to a slight decrease of intracellular pH (Bohr effect) or/and an increase
of 2,3-diphosphoglycerate (2,3-DPG) levels. Obviously, one AHT treatment has a minimal
effect and we need to ozonate at least 2.5–4 L of blood within a period of 30–60 days. During
this period, LOPs act as repeated stressors on the bone marrow and these frequent stimuli
cause the adaptation to the ozone stress during erythrogenesis with upregulation of antioxi‐
dant enzymes. As a consequence, a patient with chronic limb ischemia undergoing ozone
therapy can have a clinical improvement due to the formation of successive cohorts of
erythrocytes progressively more capable of delivering oxygen to his/her ischemic tissues.
However, the final improvement is also due to the localized release of NO, CO and growth
factors released from platelets and endothelial cells.
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Although ozone is one of the most potent disinfectants, it cannot inactivate bacteria, viruses
and fungi in vivo because, paradoxically, the pathogens are well protected, particularly inside
the cells, by the powerful antioxidant system. Thus, as it was proposed a long time ago [22,23],
ozone acts as a mild enhancer of the immune system by activating neutrophils and stimulating
the synthesis of some cytokines (2,5–7). Once again, the crucial messenger is hydrogen
peroxide, which after entering into the cytoplasm of blood mononuclear cells (BMC) by
oxidizing selected cysteines, activates a tyrosine kinase, which then phosphorylates the
transcription factor nuclear factor kB [24], allowing the release of a heterodimer (p50+p65).
This complex moves on to the nucleus and switches on some hundred genes eventually
responsible for causing the synthesis of several proteins, among which are the acute-phase
reactants and numerous interleukins. In the past, it was measured the release of several
cytokines from ozonated blood upon in vitro incubation (2–7). Once the ozonated leukocytes
return to the circulation, they home in lymphoid microenvironments and successively release
cytokines acting in a paracrine fashion on neighboring cells with a possible reactivation of a
depressed immune system [25]. This process, described as the physiological cytokine response,
is part of the innate immune system and helps us to survive in a hostile environment.
During ozonation of blood, particularly if it is anticoagulated with heparin, we have noted an
ozone dose-dependent increase of activation of platelets [8, 26] with a consequent release of
typical growth factors, which will enhance the healing of chronic ulcers in ischemic patients.
Whenever possible, the use of heparin as an anticoagulant is preferable to sodium citrate
because, by not chelating plasmatic Ca++, it reinforces biochemical and electric events.
During reinfusion of the ozonated blood into the donor, the vast expanse of the endothelial
cells will be activated by LOPs, resulting in an increased production of NO, plasma S-
nitrosothiols and S-nitrosohemoglobin [15, 27]. Whereas NO has a half-life of less than 1 sec,
protein-bound-NO can exert vasodilation also at distant ischemic vascular sites with relevant
therapeutic effect.
Moreover, on the basis of the phenomenon of ozone tolerance that says the exposure of an
organism to a low level of an agent, harmful at high levels, induces an adaptive and beneficial
response [28,29], it is postulated that LOPs, by acting as long-distance messengers, can transmit
to all organs the information of an acute oxidative stres [10, 11]. The bone marrow is particu‐
larly relevant because it can upregulate antioxidant enzymes during erythrogenesis and allows
the release of staminal cells for possibly regenerating infarcted organs. Moreover, the stimu‐
lation of the endocrine and central nervous systems may help to understand why most patients
during prolonged ozone therapy report a feeling of euphoria and wellness, probably due to
an improved metabolism as well as to an enhanced hormonal or neurotransmitter release.
The paradoxical concept that ozone eventually induces an antioxidant response capable of
reversing a chronic oxidative stress is common in the animal and vegetal kingdom and there
is good experimental evidence [30–34] that this phenomenon is present in the animal and
vegetal kingdom. Moreover, it is already supported by findings of an increased level of
antioxidant enzymes and HO-1 during ozone therapy [10,11]. It also suggests that a judicious
use of ozone, in spite of acting as an oxidant, enhances the antioxidant capacity, which
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represents the critical factor for overcoming chronic viral infections, ischemia and celldegen‐
eration.
3. A concise summary of biological effects observed after ozone therapy
3.1. Erythrocytes
These cells respond with an activation of glycolysis due to activation of the pentose hosphate
pathway. It is found that increased adenosine triphosphate levels (from 13899/260 to 19689/232
mM) in patients with age-related macular degeneration (ARMD) (atrophic form) after a
therapeutic cycle (14 sessions) of O3-AHT.26 Moreover, Viebahn [27] reported the same effect
in athletes and elderly patients after rectal insufflation of O2_/O3. Ozonation implies a small
but consistent oxidation of GSH to glutathione disulfide, and GSH reductase utilizes the
reduced form of the coenzyme nicotinamide adenine dinucleotide phosphate supplied by
G6PDH to reduce glutathione disulfide to GSH, which indeed returns rapidly to the original
level. [28] The increase of 2,3-diphosphoglycerate varies depending on the basic level in ARMD
patients and only those who had a low level showed a marked increase with therapy. Viebahn,
[27] after a longer cycle of therapy in elderly people, observed a significant increase. An
increase of 2,3-diphosphoglycerate level in oxyhemoglobin shifts to the right (p50 value
increases); its dissociation curve implies an increased delivery of O2 into the hypoxic tissues.
The life-span of ozonated 99Tc-labeled erythrocytes and their uptake by liver and spleen are
comparable with oxygenated erythrocytes.(3)
A problem still under study regards the generation of biochemically improved erythrocytes
during prolonged ozone therapy. While ROS have an extremely short life, LOPs, during the
reinfusion of ozonated blood, return into the donor’s circulation. While they are fairly stable
in vitro, they rapidly disappear from blood in vivo owing to considerable dilution into body
fluids, degradation by aldehyde dehydrogenases, excretion into bile and urine, and uptake in
various organs including bone marrow cells. This process is crucial for explaining the mech‐
anism of ozone tolerance: during erythrogenesis, submicromolar LOP concentrations can
upregulate the synthesis of antioxidant enzymes and indeed, after appropriate density
gradient separation, it is found that young (lighter) erythrocytes contain more G6PDH than
older (heavier) cells generated before the therapy. [25] This result suggests that ozone therapy
enhances the generation of erythrocytes with improved metabolic characteristics, a sort of
‘supergifted erythrocytes’ able to correct hypoxia in vascular diseases.
3.2. Leukocytes
These were the cells that were examined first as it is hypothesized that ozone could act as an
IFN-g inducer.[29] Since then it is shown [30,31] that ozone behaves as a weak (compared with
mitogens) cytokine (such as tumor necrosis factor-a, interleukin-2, interleukin-6, interleukin-8,
transforming growth factor-b [TGF-b]) inducer. Several studies [32 - 35] have confirmed that
ozone can stimulate bronchoalveolar cells to release proinflammatory cytokines and eicosa‐
noids. Thanks to parallel progress in understanding the role of antioxidants and redox
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regulation of gene transcription, it has been clarified that, among several signals, H2O2 is one
of the most significant cytokine inducers.[36] As already mentioned, after ozonation H2O2
freely diffuses into the leukocyte cytoplasm and activates specific protein kinases that, by
phosphorylating IkB bound to the nuclear factor-kB allows the migration of the transcription
heterodimer p50_/p65 into the nucleus where it activates gene expression.[37] Obviously H2O2
must reach a concentration able to activate the kinase without being instantaneously reduced
by intracellular antioxidants. [38] Therefore the relevance of the response depends on the levels
of H2O2, which can act as either ‘life or death’ signals. The fact that ozone can either be a toxic
or a useful signal depends on the minimal antioxidant capacity of the respiratory tract lining
fluid, whereas blood has a very potent capacity. The data in fact indicate that too little ozone
(hence H2O2) is ineffective and too much (or too little antioxidants) can be toxic. During recent
years it is addressed the following questions: first, as ozone acts as a mild cytokine inducer,
does reinfusion of ozonated blood modify the plasma cytokine level in vivo? Second, does the
induction of oxidative stress proteins, particularly of heme-oxygenase I (HO-I), and of
adaptation to the therapeutic oxidative stress have an immunomodulatory effect? And third,
can we devise an optimal schedule for improving the immune reactivity in immunodepressed
patients?
The classical O3-AHT, usually consisting of 225 ml of blood (plus 25 ml of 3.8% sodium citrate
solution) treated with 225 ml of gas (O2_/O3) with ozone concentrations ranging from an initial
20 mg/ml slowly scaled up to 40_/50 mg/ml per ml of blood, continued for several months,
twice weekly, is ideal for this purpose. A probable explanation is that, after each blood
reinfusion, a small percentage of immune cells are activated and home in several organs: these
cells release into the microenvironment cytokines that, in turn, prime or activate neighboring
cells thus slowly reinforcing immune responses. Modifications of cytokine plasma levels are
hardly detectable so that side effects like the flu-like syndrome, typically observed after
administration of immunoadjuvants, are absent [39] and actually most of patients report a
sense of well-being during the therapy. There is a wealth of experimental data [40 - 44] showing
that both animals and plants can develop ozone tolerance by upregulating the expression of
antioxidants, which can correct a chronic imbalance between excessive endogenous oxidation
due to viral infections, cancer, chronic inflammations and depressed antioxidants. Both chronic
hepatitis C virus and cancer patients have shown a marked improvement of their clinical
conditions after several months of O3-AHT treatments, suggesting that this ‘calculated and
brief oxidative stress’ truly merits the term ‘therapeutic shock’.
3.3. Platelets
It is known that ROS can induce platelet activation and it was obvious to assume that blood
ozonation, by generating H2O2, could cause it. [45 – 46] Moreover H2O2 or other ROS can
activate phospholipase C, phospholipase A2, cyclo-oxygenases and lipo-oxygenases and
thromboxane synthetase, allowing a step increase of intracellular Ca2_, release of prostaglan‐
din E2, prostaglandin F2a and thromboxane A2 with irreversible platelet aggregation. For
these reasons it is studied the behavior of either human platelet rich-plasma anticoagulated
with heparin or citrate, either untreated or simply oxygenated, or ozonated at three concen‐
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trations (20, 40 and 80 mg/ml). Because the plasmatic Ca2_ level potentiates the ozone effect,
we were not surprised to observe a rapid platelet aggregation in heparinized plasma particu‐
larly at the highest concentration. [47] Consequently the release of several growth factors like
platelet-derived growth factor AB, TGF-b1, interleukin-8 and thromboxane_/2 were signifi‐
cantly higher from heparinized platelets than Ca2_-free platelets. [48] These results taught us
that it is better to chelate Ca2_ for performing a safe autohemotherapy. Nonetheless the release
of growth factors from Ca2_-free platelets is still important because the reinfusion of ozonated
blood implies an elevation of plasma levels of TGF-b that may explain why the healing of
necrotic ulcers in hind limb ischemia due to atherosclerosis and diabetes markedly quickens
during treatment with both parenteral (O3-AHT) and topical treatments with ozonated water
and oil. [49 – 50]
3.4. Endothelial cells and the vascular system
During the reinfusion of ozonated blood, the endothelium comes in contact with traces of LOPs
that soon disappear in vivo. It is [51] investigated the effect of addition of ozonated (40 and 80
mg/ml) human plasma to human endothelial cells in culture and it is measured a significant
increase of the critical relaxing factor NO+that was ozone dose dependent.
The induction of nitric oxide synthase and the release of NO+was reinforced in the presence
of 20 mm of arginine and was abolished by the addition of 20 mM of L-N-omega-nitro-L-
arginine methyl ester. In physiological conditions the endothelium regulates the vascular tone
[52] by producing some 1_/10 mM of NO+and 1 nM of anion superoxide (one of the contracting
factors). The intravascular half-life of NO+is about 2 msec with a strictly localized consumption
so that the likelihood of improving vasodilation in remote ischemic areas (the macula or the
limbs) seems negligible. However, NO+readily reacts with GSH, cysteine, albumin and
hemoglobin (cysteine residue b 93) and the formed S-nitrosothiols and S-nitrosohemoglobin
have half-lives of 5_/50 min, allowing a pharmacological effect at distant sites. [53 – 54] It
remains to be ascertained whether ozonated blood enhances the release of prostacyclin (PGI2)
and angiopoietins, both important factors for improving ischemic vasculopathies.
3.5. Parenchymal cells in other organs
Upon reinfusion of ozonated blood, LOPs can reach other organs such as the hypothalamus,
endocrine glands, liver, kidneys and bone marrow. The phenomenon of adaptation to the
repeated and acute oxidative stress imposed by O3-AHT is most interesting and able to elicit
crucial therapeutic responses. During prolonged treatment, cells throughout the body receive
small and gradual pulses of LOPs that are responsible for:
1. Neuro-endocrine responses explaining the reported feeling of wellness, [55]
2. The upregulation of antioxidant enzymes in several cell types that is an excellent way to
re-equilibrate the oxidant_/antioxidant unbalance
3. Inducing a number of stress or heat shock proteins (HSPs) such as HSP27, HO-1 (HSP 32),
HSP72 and HSP [90 – 56 – 59]
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It is observed that HO-1 is a protective enzyme allowing the formation of Fe2_, bilirubin (an
antioxidant) and carbon monoxide (CO), a vasodilator that, like NO+, increases the level of
cyclic guanosine monophosphate, the reaction catalyzed by guanylate cyclase. Besides gases
produced by the gut flora, it is truly remarkable that cells can release other gaseous molecules
(NO+, CO and CO2), and it is even more surprising that even ozone can be produced by
activated antibody-coated neutrophils. [60] These gases can now be considered as molecules
able to deliver crucial physiological and pharmacological effects.
Excessive amounts of these molecules are toxic, causing serious pathological events and
possibly death. Nature teaches us that these gases, depending on their concentrations, can be
either friends or foes and similarly ozone therapy can be either useful or toxic. If this reasoning
is correct, ozone therapy, when judiciously performed, is a simple, inexpensive and atoxic
approach with the advantage of activating several biomechanisms in different cells unusually
leading to an integrated and often incredible response.
4. The extreme versatility of ozone therapy
The sarcastic comment of the opponents is that ozone therapy looks like a panacea for all
diseases. Indeed it seems so, but in reality this is due to the multitude of compounds originated
at first from the reaction of ozone with body fluids, and eventually able to display pleiotropic
effects delivered by different organs. For the sake of brevity we can only summarize the
therapeutic effects so far reported
Specialization Pathology
Dermatology Herpes Zoster and simplex, acne, eczema, lipodystrophy (cellulite), mycosis, psoriasis, atopic
dermatitis
Internal Medicine Hepatitis, diabetes, atherosclerosis, arterial hypertension, osteoarthritis, asthma, chronic
bronchitis, gastritis, gastric ulcer, Crohn's disease, chronic constipation, hypothyroidism.
Nephrology / Dialysis Adjuvant in the treatment of ischemic-metabolic pathologies.
Neurology Migraines, depression, vasomotor cephalea, neuro-vascular disorders.
Dentistry Treatment of cavities, disinfection of cavities during surgery and post-operatory period.
Periodontitis, aphthas.
Orthopedic Rheumatology Disc-radicular conflicts, disc herniation, articular rheumatism, lumbago, osteoarthritis,
arthropathy, periarthritis, rheumatoid arthritis.
Angiology Venous insufficiency, diabetic ulcer, arthropathy, coronaropathy, gangrene, postphlebitic
ulcer, peripheral vasculopathy.
Gynecology Bacterial infections by protozoa or mycosis, Bartholin's cyst, vaginitis, menopause, chronic
pelvic inflammation, infertility.
Immunology Immuno-modulator, autoimmune disorders, adjuvant in treatments with radiation and in
immunodeficiency.
Table 1. Indiciations of Ozone Therapy in General
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4.1. Acute and chronic bacterial, viral and fungine infections
Intuitively, ozone therapy is very useful in both acute and chronic bacterial, viral and fungine
infections because the generated ROS are the natural and most effective agents to which even
antibiotic resistant pathogens do not resist. [3-61] Moreover, improvement of metabolism and
immunological functions contribute to a favorable outcome. Abscesses, anal fissures, fistulae,
bed sores, furunculosis, inveterate osteomyelitis, vulvovaginitis, necrotizing fasciitis and
torpid ulcers of various origin have been shown to improve rapidly, particularly using the
combination of O3-AHT with topical treatment using either direct O2_/O3 exposure or the
cleansing and stimulating effect of ozonated water and oil. The activity of ozonated solutions
in eliminating the infectivity and enhancing healing is almost unbelievable. However, in
Western countries accustomed to the use of antibiotic creams (often with corticosteroids) there
is no mental attitude to profitably use the inexpensive and most active ozonated oil. [62]
4.2. Ischemic diseases
Chronic limb ischemia (atherosclerosis, diabetes, Burger’s disease) is most effectively treated
at stage II-b with complete disappearance of pain and claudication. Moreover, since 1981,
Rokitansky et al.[49] demonstrated that a cycle of O3-AHT (usually 14 treatments) led to a very
good improvement in 70.6% and 53.8% of either stage III or stage IV (Fontaine) patients,
respectively. Amputation of toes and limbs could be avoided in pre-terminal phases.
These results have been amply confirmed by Giunta et al.,[63] Mattassi et al. [64] and Tylicki
et al.[65] Preterminal patients with chronic heart ischemia and no further susceptibility to
conventional treatments have shown marked improvement after a cycle of 14 treatments of
extracorporeal circulation of blood against O2_/O3.[66] A randomized controlled study is in
progress for establishing the validity of this more invasive method than classical O3-AHT.
4.3. Age-related macular degeneration
A 6-year study in 90 patients with the ‘dry’ form of ARMD has been carried out performing a
cycle of 13_/14 O3-AHT treatments. Mean distance best-corrected visual acuity was signifi‐
cantly improved in the treatment group of patients while in the control group, first treated
with oxygenated autohaemotherapy, only a modest and not significant improvement in mean
distance visual acuity was observed. No adverse effects have been noted and the patient’s
compliance has been excellent. [26] Owing to the constant increase of ARMD patients and the
lack of an effective conventional treatment, this approach appears mandatory.
4.4. Orthopedic diseases
Until recently it was unthinkable that a mixture of O2_/O3 could be useful in orthopedics.
Indeed lumbar disk herniation and osteoarthritis, although having different etiologies, have a
common inflammatory background expressed by a localized chronic oxidative stress due to
excessive production of ROS, release of proinflammatory cytokines and activation of cyclo‐
xygenases. Common sense would proscribe the use of ozone, a master generator of free radicals
and, as it is well shown, [34 – 67] after pulmonary exposure, a superb inflammatory agent.
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Contrary to all expectations, it is now well demonstrated [68] that combined intradiscal and
periganglionic injection of medical ozone allows an excellent outcome in 70.3% of patients
treated for disk herniation performed after conservative management failed to respond. In the
same vein, it appears very surprising that the application of medical ozone in acute and chronic
painful diseases of the joints allows rapid pain relief, disappearance of inflammation and
improvement of mobility. Thousands of patients have been successfully treated and the lack
of side effects is noteworthy. [69] These positive empiric observations need to be explained.
Ozone is indeed a surprising gas that paradoxically, after prolonged administration at low
concentrations, induces tolerance, a phenomenon termed ‘hormesis’ by Goldman [70] to
indicate ‘a beneficial effect of a low level exposure to an agent that is harmful at high levels’.
Thus, at this stage, we use the definition of ‘ozone paradox’ for explaining these excellent
therapeutic results. Immediately after O2_/O3 administration in the nucleus pulposus or into
inflamed endoarticular cavities; a sort of oxidative shock seems to subvert all the traditional
rules by inducing an antioxidative response due to several factors, among which is the
cholinergic antiinflammatory pathway. [71] A detailed discussion is reported elsewhere. (3)
4.5. Dentistry
This is another medical specialty where ozone has been recently evaluated with exceedingly
interesting results.[72] Primary root carious lesions are being treated with a novel ozone
delivery system able to avoid any toxic risk for the mouth cavity and lungs. The tooth’s lesion
is exposed for 10_/20 sec to a sort of ozone ‘hurricane’ based on a gas flow of 615 ml/min of
O2_/O3 at a low concentration (4 mg/ml), perfectly enclosed in a tightly fitting silicone cup
enclosing the tooth. It is not surprising that all bacteria, particularly lactobacilli, are destroyed
so that the ozone-sterilized dental surface becomes quickly remineralized, becoming hard and
resistant to further bacterial attack. This new approach is simple, inexpensive and well
tolerated, as opposed to the conventional and painful ‘drilling and filling’ management of
primary root carious lesions. Dermatological, pulmonary, renal, hematological and neurode‐
generative diseases Owing to the ability of ozone to activate a number of biological targets,
ozone therapy could be proficiently used in some dermatological, pulmonary, renal, hemato‐
logical and neurodegenerative diseases. However these pathologies so far have not been
evaluated in a controlled fashion. Most of the patients with metastatic cancer resistant to
radiotherapy and chemotherapy report a striking improvement of the quality of life with
prolonged (twice weekly for months) O3-AHT treatments. [25 – 73] This is a constantly
observed result, most probably due to a multifactorial neuroendocrine response.
5. Summary
Finally it must be emphasized that if ozone is judiciously used according to precisely defined
guidelines, it causes neither acute, nor chronic side effects. After two decades of practical
applications and the results observed in patients after conventional remedies have proved
unsatisfactory. One has the feeling that, if ozone therapy could be accepted and used in all
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hospitals, it would represent a small but important medical revolution able to cure or stabilize
several diseases in many patients in both rich and poor countries.
6. Discussion and conclusions
There is no doubt that ozone can be toxic, and even today its hazardous employment by
charlatans and unprepared physicians has contributed to a poor consideration of ozone
therapy. That is one reason why the use of ozone is prohibited in some states of the USA and
why this therapy is still regarded with skepticism by orthodox medicine even in Germany,
where this approach was first conceived. Moreover, the following data tend to generalize that
ozone is always toxic and should not be used in medicine:
1. Overwhelming evidence shows that the bronchial-pulmonary system is very sensitive to
ozone and this gas should never be inhaled. [67]
2. This is very true because the respiratory tract lining fluid is constituted by a very thin,
watery film containing a minimal amount of antioxidants that makes mucosal cells
extremely vulnerable to oxidation. The opposite situation occurs for blood cells suspended
in plasma, which has a potent antioxidant capacity (1.23_/1.83 mmol/l) able to tame any
ozone dose within the therapeutic range (10_/80 mg/ml).
3. Saline-washed erythrocytes suspended in saline undergo extensive hemolysis after ozone
exposure. [12]
4. Cells in culture, even if exposed to very low ozone concentrations for a long time, undergo
apoptosis. [74]
5. One-hour exposure of saline-diluted blood to 5 mM of ozone induces genotoxic effects on
leukocyte. [75]
But is ozone always toxic?
As a matter of fact millions of O3-AHT, even if performed in an empirical fashion during the
past three decades, has neither yielded acute nor chronic toxic effects. According to Jacobs [76]
this procedure has yielded the lowest number of medical complications.
However, four deaths have been recorded due to pulmonary embolism, which occurred
during direct intravenous administration of O2_/O3, an application prohibited by the Euro‐
pean Society of Ozonetherapy since 1983. Thus ozone seems like Janus and his two faces
require an explanation. This is now reasonably clear. Since 1988 we have investigated the
problem in a scientific way using precise ozone generators, which allow checking ozone
concentration in real time by a photometer calibrated with the classical iodometric method. A
review [61] and a critical book (3) have extensively clarified the issue but this does not seem
sufficient to dispel the dogma that ‘ozone is always toxic’. However, we now consider ozone
as a real drug that must be used with caution after having carefully defined its therapeutic
window. First, the ozone must be calibrated against the antioxidant capacity of the patient’s
blood in order to control the potential ozone toxicity
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Second, expert scientists in free radicals ought to distinguish the chronic intracellular oxidative
stress typical of several pathologies by the transitory (5 min) calculated oxidative stress
occurring when a precise volume of blood is exposed ex vivo to an equal volume of gas (O2_/
O3) with well-defined ozone concentrations ranging from 20 up to 40 mg/ml per ml of blood.
It needs to be emphasized that the exogenous oxidative stress caused by ozone in blood is due
to the fact that ozone, once dissolved in the plasmatic water, instantaneously reacts with
biomolecules and disappears but generates ROS, among which are H2O2 and LOPs. These are
the effective ozone messengers that interact with a variety of cells and elicit the now-termed
‘therapeutic shock’ due to the multiform biological responses. That ozone acts as a real
chemical drug is proved by the fact that the ozone messengers, to be effective, must reach a
threshold because otherwise there are no biological effects and the therapeutic results, if any,
are due to a placebo effect. Although we have proven that ozone therapy is not a nebulous
approach and has been shown amenable to a precise scientific scrutiny, it is probable that much
still remains to be uncovered.
Everyone knows that plasma and blood cells contain an almost redundant antioxidant system
made up of hydro-liposoluble compounds and antioxidant enzymes. During aging or patho‐
logic conditions, this is not sufficient to correct the intracellular oxidative stress, but normally
it is adequate to tame ozone toxicity while allowing the generation of ROS and LOPs. Thus all
data emphasizing ozone toxicity can be easily dismissed because the following is now well
proven:
1. Blood is a much more ozone-resistant ‘tissue’ than the respiratory tract that, for anatomic,
biochemical and metabolic reasons, is always at a loss when exposed to ozone, and
therefore it is wrong to extrapolate ozone toxicity for the pulmonary system to blood.
2. Washed and saline-resuspended erythrocytes, fully depleted of the plasmatic antioxi‐
dants, are obviously very sensitive to ozonation, and all of these unnatural data have
neither physiological nor practical significance.
3. The same occurs for cells cultured in antioxidant-poor media and exposed continuously
for days to ozone. Surprisingly, cell biologists reported only the ozone concentration but
have neither calculated nor taken into account the cumulative dose of ozone that after a
long exposure kills the cells.
4. The conclusion is that, although ozone is potentially mutagenic, so far all experimental
data performed in physiological conditions and clinical evidence have neithershown any
cell damage nor adverse effects in patients. As a matter of fact, blood is exposed to ozone
concentrations (0.21_/1.68 mM) lower than the mutagenic ones (1.5_/5.6 mM). The
question of whether ozone is genotoxic and mutagenic is a critical one and has been
extensively discussed elsewhere. (3) What has never been entirely appreciated is the fact
that we can only use an ozone dose that does not overwhelm the antioxidant capacity of
blood.
Hopefully this discussion should put an end to the confusion between the endogenously
constant oxidative stress due to the oxygen and the transitory and occasional therapeutic
‘shock’ due to precise blood ozonation. A point that should not be overlooked is that ozone
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messengers, by acting on different cells, elicit a variety of biological effects that cannot ever be
dreamed of with the usual reductionist approach of using a drug for a single target. This
consideration can explain the far superior therapeutic effect of parenteral and topical ozone
therapy in advanced cases of chronic limb ischemia to the conventional infusion of prostanoids.
Another relevant characteristic is that the judicious strategy ‘start low, go slow’ in using ozone
is able to induce in patients the adaptation to the chronic oxidative stress (i.e. ozone) para‐
doxically upregulates the antioxidant defenses. The scientific evaluation of ozone therapy
efficacy remains the crucial point: results accrued during the past 20 years show that is very
useful in chronic limb ischemia, ARMD, chronic infectious diseases and, most surprising, in
orthopedics and even in dentistry after conventional medicine has failed to provide a real
advantage. There are no adverse effects and most of the patients report a feeling of wellness.
The efficacy remains uncertain in other pathologies such as neurodegenerative, autoimmune
diseases and cancer because clinical experience is fragmentary and anecdotal.
However, orthodox medicine remains skeptical because controlled clinical trials are few and
are not considered satisfactory. Unfortunately our good will is not sufficient to overcome
prejudice and lack of sponsors. It is distressing to realize that a wrong dogma, commercial
interests and the disinterest of Health Authorities delay the application of a medical approach
that could help billions of patients, particularly in poor countries. Finally, this paper may serve
the purpose of opening a fruitful discussion on the beneficial versus the toxicological actions
of ozone, and a referee has proposed that the debate may be hosted as a forum by Mediators
of Inflammations.
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